Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review
Sheena G Sullivan, Shuo Feng, Benjamin J Cowling
Expert Review of Vaccines | TAYLOR & FRANCIS LTD | Published : 2014
Awarded by Area of Excellence Scheme of the Hong Kong University Grants Committee
Awarded by Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences
BJ Cowling has received research funding from MedImmune Inc. and Sanofi Pasteur for influenza vaccine efficacy and effectiveness studies, and has consulted for Crucell NV on pharmaceutical options for influenza control. This work has received financial support from the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant no. AoE/M-12/06) and the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant no. U54 GM088558). The WHO Collaborating Centre for Reference and Research on Influenza is funded by the Australian Government Department of Health. The funding bodies were not involved in the collection, analysis and interpretation of data, the writing of the article or the decision to submit it for publication. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.